BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ReVance Therapeutics, Inc. 

2400 Bayshore Parkway, Suite 100

Mountain View  California  94043  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
ReVance Therapeutics, Inc. (RVNC) Added To Russell 2000® And 3000® Indexes 4/1/2014 10:58:57 AM    More...
ReVance Therapeutics, Inc. (RVNC) Releases Fourth Quarter And Full Year 2013 Financial Results And Provides 2014 Outlook 3/27/2014 9:23:53 AM    More...
ReVance Therapeutics, Inc. (RVNC) To Release Fourth Quarter And Full Year 2013 Financial Results And Host Conference Call On Wednesday, March 26, 2014 3/13/2014 9:32:32 AM    More...
ReVance Therapeutics, Inc. (RVNC) To Add Angus C. Russell As Chairman To Its Board Of Directors 3/5/2014 9:40:07 AM    More...
ReVance Therapeutics, Inc. (RVNC) Announces Participation In Cowen 34th Annual Health Care Conference 2/20/2014 9:19:13 AM    More...
ReVance Therapeutics, Inc. (RVNC) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Over-Allotment Option 2/12/2014 9:12:10 AM    More...
Bay Area's ReVance Therapeutics, Inc. (RVNC) Prices IPO At Top Of Range, Raises $96 Million 2/6/2014 7:51:42 AM    More...
ReVance Therapeutics, Inc. Files $86.25 Million IPO 1/2/2014 7:12:49 AM    More...
ReVance Therapeutics, Inc. Scores $33 Million in Series E Financing 4/2/2013 6:57:08 AM    More...
ReVance Therapeutics, Inc. Settles With Medicis (MRX) for Up to $25 Million, Regains Global Rights to Botulinum Toxin Products 10/8/2012 7:20:29 AM    More...
12

//-->